Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Non-Current Assets (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Non-Current Assets for 9 consecutive years, with $2.5 million as the latest value for Q3 2024.

  • On a quarterly basis, Non-Current Assets changed N/A to $2.5 million in Q3 2024 year-over-year; TTM through Sep 2024 was -$19.8 million, a N/A change, with the full-year FY2023 number at $3.0 million, changed N/A from a year prior.
  • Non-Current Assets was $2.5 million for Q3 2024 at SELLAS Life Sciences, down from $3.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $9.2 million in Q3 2020 to a low of -$28.7 million in Q2 2022.
  • A 5-year average of $1.6 million and a median of $3.4 million in 2022 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 273.05% in 2021, then plummeted 417.57% in 2022.
  • SELLAS Life Sciences' Non-Current Assets stood at $9.1 million in 2020, then plummeted by 64.59% to $3.2 million in 2021, then grew by 5.11% to $3.4 million in 2022, then fell by 10.28% to $3.0 million in 2023, then fell by 18.94% to $2.5 million in 2024.
  • Per Business Quant, the three most recent readings for SLS's Non-Current Assets are $2.5 million (Q3 2024), $3.0 million (Q4 2023), and $3.4 million (Q3 2022).